Jin Medical International Ltd. has announced the completion of a share subdivision following shareholder approval at an extraordinary general meeting on January 30, 2024. The subdivision, effective February 8, 2024, will see each existing ordinary share with a par value of US$0.001 divided into twenty new ordinary shares with a par value of US$0.00005 each. This change increases the total number of authorized shares to 1,000,000,000 with the adjusted par value. Shareholders will not receive fractional shares but can contact the transfer agent, Transhare Corporation, for instructions on exchanging their share certificates to reflect the subdivision. The announcement was made in compliance with the SEC regulations and signed by CEO Erqi Wang on February 5, 2024.

Jin Medical International Ltd. has announced the completion of a share subdivision following shareholder approval at an extraordinary general meeting on January 30, 2024. The subdivision, effective February 8, 2024, will see each existing ordinary share with a par value of US$0.001 divided into twenty new ordinary shares with a par value of US$0.00005 each. This change increases the total number of authorized shares to 1,000,000,000 with the adjusted par value. Shareholders will not receive fractional shares but can contact the transfer agent, Transhare Corporation, for instructions on exchanging their share certificates to reflect the subdivision. The announcement was made in compliance with the SEC regulations and signed by CEO Erqi Wang on February 5, 2024.